Document is current

Article History

Received: 23 September 2018

Accepted: 20 December 2018

First Online: 8 January 2019

Ethics approval and consent to participate

: The study was conducted in compliance with the declaration of Helsinki, US Code of Federal Regulations Title-21, and the Harmonized Tripartite Guidelines for Good Clinical Practice (1996). The study was approved by the local Institutional Review Board. A written informed consent was obtained from all participants.

: Not applicable.

: YJS has received research support from Astellas, Genentech, and Optovue, and serves on the Scientific Advisory Board for Genentech/Roche, Optos, and Regeneron.QDN is a recipient of a Physician Scientist Award from Research to Prevent Blindness, New York, NY, and serves on the Scientific Advisory Board for AbbVie, Bayer, Genentech, Regeneron, and Santen, among others. QDN also chaired the Steering Committee for the RISE and RIDE studies and was on the Steering Committee for the VISTA Study, and other studies sponsored by Genentech and Regeneron.No other authors have received any financial funding or support.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.